randomization [Design Issues]

posted by bala  – Bangalore, India, 2009-01-21 14:10 (6362 d 10:41 ago) – Posting: # 3092
Views: 5,260

Dear Neethu...

This is the first time I m hearing this kind of study... In FDA and other guidelines I am not able to locate this kind of study, however I will give you one layout for this...

Totally 24 subjects Sequences
1. T R T
2. T T R
3. R T T


We can randomize 8 patients with sequences (1,2)
8 patients with sequences (1,3)
8 patients with sequences (2,3)

Where subjects who were assigned (1,2) will receive T R T T T R in the 6 periods...

Similarly the others...

Just check with your protocol whether its allowing this...

Cheers
Bala

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
126 visitors (0 registered, 126 guests [including 19 identified bots]).
Forum time: 01:52 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5